Drug Profile
Monopharm C
Latest Information Update: 07 Feb 2008
Price :
$50
*
At a glance
- Originator Viventia Biotech
- Class Monoclonal antibodies; Monoclonal antibody diagnostics; Radiopharmaceutical diagnostics
- Mechanism of Action Immunomodulators; Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Colorectal cancer; Pancreatic cancer
Most Recent Events
- 31 Jan 2001 No development reported - Phase-I for Colorectal cancer in Japan (IV)
- 31 Jan 2001 No development reported - Phase-I for Pancreatic cancer in Japan (IV)
- 31 Jan 2001 No development reported - Phase-I for Colorectal cancer diagnosis in Japan (IV)